Previous 10 |
home / stock / drug:cc / drug:cc news
-- Herbert Y. Meltzer, MD; Karl Deisseroth, MD, PhD; Robert C. Malenka, MD, PhD; Michael P. Bogenschutz, MD; and Peter Hendricks, PhD, bring decades of clinical and research expertise in psychiatry, addiction, behavioral health, and pharmacology to guide Company’s development program...
-- Review of Phase I ready BMB-101 and upcoming milestones -- -- Conference call to be held on May 19, 2022, 10:00am ET -- VANCOUVER, British Columbia, April 19, 2022 (GLOBE NEWSWIRE) -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Com...
News, Short Squeeze, Breakout and More Instantly...
Bright Minds Biosciences Inc. Company Name:
DRUG:CC Stock Symbol:
CNQC Market:
Bright Minds Biosciences Inc. Website:
A look at the top 10 most actives in Canada Ivanhoe Mines Ltd. (IVN) fell 9.6% to $18.64 on volume of 19,471,224 shares Canopy Growth Corporation (WEED) rose 78.2% to $20.24 on volume of 19,456,911 shares Enbridge Inc. (ENB) fell 0.4% to $48.95 on volume of 18,616,928 shares Tilray Bran...
A look at the top 10 most actives in Canada Auxly Cannabis Group Inc. (XLY) rose 100.0% to $0.06 on volume of 25,275,816 shares Canopy Growth Corporation (WEED) rose 15.2% to $9.8 on volume of 18,760,847 shares Toronto-Dominion Bank (The) (TD) rose 0.1% to $81.04 on volume of 18,116,348 s...
Bright Minds Announces Non-Brokered Private Placement Fully Subscribed by Management Canada NewsWire /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITE...